Redesigner drugs.
Drug development is a risky business, and the final product can have serious, sometimes deadly flaws. But by focusing on fixing those flaws, companies are catapulting themselves to profitability.
Alan
A
Dove
D016503:Drug Delivery Systems / Q000379:methods* / Q000639:trends; D015195:Drug Design; D004345:Drug Industry / Q000191:economics* / Q000379:methods* / Q000639:trends; D004358:Drug Therapy / Q000191:economics* / Q000379:methods* / Q000639:trends; D005062:European Union; D010067:Ownership / Q000191:economics / Q000639:trends; D010330:Patents as Topic; D004364:Pharmaceutical Preparations / Q000191:economics*; D014481:United States
D004364:Pharmaceutical Preparations